Great West Life Assurance CO G1 Therapeutics, Inc. Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$5.19 - $13.5 $10,514 - $27,351	2,026 New	2,026 $11,000
Q2 2022 Aug 09, 2022	SELL	$4.04 - $8.51 $9,199 - $19,377	-2,277 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$11.55 - $23.75 $1.35 Million - $2.77 Million	-116,825 Reduced 98.09%	2,277 $26,000
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $1.35 Million - $2.77 Million	116,825 Added 5130.65%	119,102 $1.38 Million
Q4 2019 Feb 11, 2020	BUY	$20.54 - $31.0 $46,769 - $70,587	2,277 New	2,277 $60,000
Q3 2019 Oct 25, 2019	SELL	$22.78 - $40.58 $59,501 - $105,994	-2,612 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$35.06 - $51.17 $54,693 - $79,825	1,560 Added 148.29%	2,612 $113,000
Q4 2017 Feb 09, 2018	BUY	$19.01 - $26.2 $19,998 - $27,562	1,052	1,052 $21,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.